XML 53 R38.htm IDEA: XBRL DOCUMENT
v3.10.0.1

INTANGIBLE ASSETS (Details Narrative) | 3 Months Ended | 6 Months Ended
--- | --- | ---
Jun. 30, 2018 USD ($) Number | Jun. 30, 2017 USD ($) | Jun. 30, 2018 USD ($) Number | Jun. 30, 2017 USD ($)
Finite-Lived Intangible Assets [Line Items] |  |  |  |
Amortization expense | $ | $ 24,826 | $ 17,789 | $ 46,023 | $ 33,888
Approved Hormone Therapy Drug Candidate Patents [Member] |  |  |  |
Finite-Lived Intangible Assets [Line Items] |  |  |  |
Useful Life |  |  | 20 years |
Domestic U.S. Patents [Member] |  |  |  |
Finite-Lived Intangible Assets [Line Items] |  |  |  |
Number of issued patents | 19 |  | 19 |
Foreign Patents [Member] |  |  |  |
Finite-Lived Intangible Assets [Line Items] |  |  |  |
Number of issued patents | 20 |  | 20 |
Domestic Utility Patents [Member] |  |  |  |
Finite-Lived Intangible Assets [Line Items] |  |  |  |
Number of issued patents | 13 |  | 13 |
Domestic Patents - TX-004HR [Member] |  |  |  |
Finite-Lived Intangible Assets [Line Items] |  |  |  |
Number of issued patents | 3 |  | 3 |
Domestic Utility Patent - Pipeline Transdermal Patch Technology [Member] |  |  |  |
Finite-Lived Intangible Assets [Line Items] |  |  |  |
Number of issued patents | 1 |  | 1 |
Domestic Utilty Patent - Opera Software [Member] |  |  |  |
Finite-Lived Intangible Assets [Line Items] |  |  |  |
Number of issued patents | 1 |  | 1 |
Domestic Patents - TX-009HR [Member] |  |  |  |
Finite-Lived Intangible Assets [Line Items] |  |  |  |
Number of issued patents | 1 |  | 1 |

X
- Definition Number of issued patents. + References No definition available. + Details
Name: | txmd_NumberOfIssuedPatents
Namespace Prefix: | txmd_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a)(2) -URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275 + Details
Name: | us-gaap_AmortizationOfIntangibleAssets
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | us-gaap_FiniteLivedIntangibleAssetUsefulLife
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_FiniteLivedIntangibleAssetsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=txmd_ApprovedHormoneTherapyDrugCandidatePatentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=txmd_Patents5Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=txmd_Patents3Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=txmd_Patents1Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=txmd_Patents4Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=txmd_Patents2Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=txmd_Patents9Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |